Lead Product(s): Isavuconazonium Sulfate
Therapeutic Area: Infections and Infectious Diseases Product Name: Cresemba
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Pfizer Inc
Deal Size: $0.5 million Upfront Cash: Undisclosed
Deal Type: Licensing Agreement July 15, 2020
Basilea Pharmaceutica reported that its license partner, Pfizer has launched the antifungal Cresemba® (isavuconazole) in Taiwan.